Role of pRB dephosphorylation in cell cycle regulation

S Tamrakar1, E Rubin, J W Ludlow

  • 1Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, New York 14642, USA.

Insights

The retinoblastoma protein (pRB) regulates cell cycle progression. This review focuses on pRB dephosphorylation by protein phosphatase 1 (PP1) at mitosis completion, restoring its tumor-suppressive function.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The retinoblastoma protein (pRB) is a critical tumor suppressor regulating cell cycle progression.
  • pRB's activity is modulated by its phosphorylation state, affecting its interaction with cellular proteins.
  • While pRB phosphorylation is well-studied, its dephosphorylation remains less understood.

Purpose of the Study:

  • To review the role of pRB dephosphorylation in cell cycle regulation.
  • To explore the function and regulation of pRB during the cell cycle.
  • To examine the interaction between pRB and protein phosphatase 1 (PP1) and the mechanism of pRB dephosphorylation.

Main Methods:

  • Literature review focusing on pRB dephosphorylation.
  • Analysis of existing research on pRB function and cell cycle control.
  • Examination of the molecular mechanisms of pRB-PP1 interaction.

Main Results:

  • Hypophosphorylated pRB inhibits cell cycle progression by sequestering E2F/DP transcription factors.
  • Phosphorylation by cyclin/cdk complexes abrogates pRB's inhibitory function.
  • pRB dephosphorylation by a PP1 complex at mitotic exit restores its active, growth-suppressive state.

Conclusions:

  • pRB dephosphorylation is a crucial step in cell cycle regulation, reactivating its tumor-suppressive role.
  • Understanding pRB-PP1 interactions provides insights into cell cycle control and potential therapeutic targets.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...